GB8514519D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB8514519D0
GB8514519D0 GB858514519A GB8514519A GB8514519D0 GB 8514519 D0 GB8514519 D0 GB 8514519D0 GB 858514519 A GB858514519 A GB 858514519A GB 8514519 A GB8514519 A GB 8514519A GB 8514519 D0 GB8514519 D0 GB 8514519D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB858514519A
Other versions
GB2161803A (en
GB2161803B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB08221059A external-priority patent/GB2107307B/en
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Priority to GB08514519A priority Critical patent/GB2161803B/en
Publication of GB8514519D0 publication Critical patent/GB8514519D0/en
Publication of GB2161803A publication Critical patent/GB2161803A/en
Application granted granted Critical
Publication of GB2161803B publication Critical patent/GB2161803B/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/12—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 3 and unsubstituted in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB08514519A 1981-07-25 1985-06-07 Intermediates for b-lactam antibiotics Expired GB2161803B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB08514519A GB2161803B (en) 1981-07-25 1985-06-07 Intermediates for b-lactam antibiotics

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
GB8123033 1981-07-25
GB8123034 1981-07-25
GB8136823 1981-12-07
GB8136824 1981-12-07
GB8207966 1982-03-18
GB8209954 1982-04-03
GB8209953 1982-04-03
GB8215007 1982-05-22
GB08221059A GB2107307B (en) 1981-07-25 1982-07-21 B-lactum antibacterial agents
GB08514519A GB2161803B (en) 1981-07-25 1985-06-07 Intermediates for b-lactam antibiotics

Publications (3)

Publication Number Publication Date
GB8514519D0 true GB8514519D0 (en) 1985-07-10
GB2161803A GB2161803A (en) 1986-01-22
GB2161803B GB2161803B (en) 1986-07-23

Family

ID=27579361

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08514519A Expired GB2161803B (en) 1981-07-25 1985-06-07 Intermediates for b-lactam antibiotics

Country Status (1)

Country Link
GB (1) GB2161803B (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1348985A (en) * 1970-06-16 1974-03-27 Merck & Co Inc Esters of cephalosporin compounds
CA1018968A (en) * 1972-12-06 1977-10-11 Joseph E. Dolfini Method for preparing 7-substituted cephalosporins by replacement of o- or s-containing groups
US3962214A (en) * 1974-07-11 1976-06-08 Eli Lilly And Company Process for preparing amino substituted β-lactam antibiotics

Also Published As

Publication number Publication date
GB2161803A (en) 1986-01-22
GB2161803B (en) 1986-07-23

Similar Documents

Publication Publication Date Title
GB2111488B (en) 1-oxa- and 1-thia-spirocyclic compounds
JPS57150694A (en) Compound
PT75620B (en) Novel compounds
GB2101580B (en) Allophanoylpiperazine compounds
GB2097003B (en) Phosporus-containing compounds
PT74377B (en) Novel compounds
GB2098604B (en) 3-substituted-2-azetidinone compounds
JPS57163384A (en) Benzopyranoimidazole compounds
GB2106519B (en) Aminooxazolyl compounds
GB2111999B (en) Trihydroxyvitamin d3 compounds
GB2104365B (en) Cloches
GB2104889B (en) Phenethylpiperidine compounds
ZA812706B (en) Gas-scrubber
DE3260771D1 (en) Pyridothienopyridazine compounds
GB2092587B (en) Substituted phenylcarbamoylbenzimidates
GB2096998B (en) Dioxaazabicyclic compounds
GB2105449B (en) Graindryer
ZA825525B (en) Novel compounds
ZA828688B (en) Novel compounds
ZA823153B (en) Substituted 2-aminoethanols
ZA829329B (en) Novel compounds
JPS57212140A (en) Substituted azolylalkylphenoxybenzoate
CS34682A1 (en) Zpusob vyroby reagencniho papiru
GB2113676B (en) M-hydroxypheny1 substituted compounds
IE810403L (en) 2-penem compounds

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19920721